CSF Phosphorylated Tau Protein and Mild Cognitive Impairment: A Prospective Study
- 30 November 2000
- journal article
- research article
- Published by Elsevier BV in Experimental Neurology
- Vol. 166 (1), 201-203
- https://doi.org/10.1006/exnr.2000.7501
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Lysosomal Protease Inhibitors Induce Meganeurites and Tangle-like Structures in Entorhinohippocampal Regions Vulnerable to Alzheimer's DiseaseExperimental Neurology, 1999
- Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's diseaseNeuroscience Letters, 1999
- Translating cell biology into therapeutic advances in Alzheimer's diseaseNature, 1999
- Prediction of AD with MRI-based hippocampal volume in mild cognitive impairmentNeurology, 1999
- Mild Cognitive ImpairmentArchives of Neurology, 1999
- No increase in cerebrospinal fluid tau protein levels in patients with vascular dementiaNeuroscience Letters, 1998
- Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's diseaseNeurology, 1997
- Cerebrospinal protein tau is elevated in early Alzheimer's diseaseNeuroscience Letters, 1996
- Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s DiseaseJournal of Neuroscience, 1996
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984